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LIST OF ABBREVIATIONS 
NPDR -  Non proliferative diabetic retinopathy 
CSME - Clinically significant macular edema 
CME - Cystoid macular edema 
DME - Diabetic Macular edema  
OCT - Optical coherence tomography 
FFA - Fundus fluorescin angiography 
IVTA - Intra vitreal triamcinolone 
VEGF - Vascular endothelial growth factor 
ILM - Internal Limiting Membrane 
IRMA         -        Intra retinal microvascular anomaly 
  
INTRODUCTION 
Contrast sensitivity is an important aspect of visual function and 
is even more important for ordinary daily tasks than visual acuity.  
Contrast sensitivity function may be deteriorated to a significant 
level in diabetic retinopathy, especially in diabetic macular edema. 
Diabetic macular edema is a microvascular complication of diabetes 
mellitus defined as retinal thickening resulting from the accumulation of 
fluid in the retina. When it is associated with hard exudates, both retinal 
damage and permanent visual loss will occur. 
 Diabetic macular Odema is one of the major causes for moderate 
vision loss in diabetic patients. Laser photocoagulation is the treatment 
modality for DME either focal or grid laser is done which reduces the 
odema thus improving the vision and contrast sensitivity. The objective 
of this study was to determine the impact of macular laser 
photocoagulation as the standard treatment of clinically significant 
macular edema on contrast sensitivity. 
  
ANATOMY OF THE MACULA 
 Macula is the optical, functional and organic focal point of the 
eye. It is the precise visual functions of acuity, form sense, colour 
differentiation and stereopsis. 
 According to Wolff, the macula is an oval zone of yellow 
coloration within the central retina approximately 5mm in diameter. The 
yellow colour of the macula is probably due to the presence of 
carotenoid pigment xanthophll in the ganglion cells and bipolar cells in 
this area.  
The side walls  of the macula is the clivus which slopes gently 
towards the fovea centralis. Fovea is the center of the area centralis and 
is located 4mm temporal to the center of the optic disc and 0.8mm 
below the horizontal meridian. Its thickness is 0.25mm, diameter is 
1.85mm and it corresponds  to 5 degrees of visual field. Foveola is at the 
center of the fovea where the retinal layers are thinner. It is of thickness, 
0.35mm diameter and it corresponds  to 1 degrees of visual field. It is 
the area of highest visual acuity because of the sole presence of cone 
receptors and its avascularity. It appears deeper red than the adjacent 
retina because of the rich choroidal circulation and abundant 
choriocapillaris. 
HISTOPATHOLOGY 
The retina as such has 10 layers which are as follows 
1. Retinal pigment epithelium 
2. Photoreceptors layer of rods and cones 
3. External limiting membrane 
4. Outer nuclear layer 
5. Outer plexiform layer 
6. Inner nuclear layer 
7. Inner plexiform layer 
8. Ganglion cell layer 
9. Nerve fibre layer 
   10. Internal limting membrane 
At the fovea the only layers present are the 
1. Retinal pigment epithelium 
2. Photoreceptors layer only cones 
3. External limiting membrane 
4. Outer nuclear layer 
5. Henles layer 
6. Internal limiting membrane 
Thus the fovea has no inner nuclear layer, inner plexiform layer, 
or no ganglion cell layer and practically no nerve fibre layer. 
At the macula ganglion cells are much more than elsewhere in the 
retina, being arranged in several layers.  
Outer plexiform layer is made up of arborisation of axons of rods 
and cones with bipolar cell dendrites, it also includes muller’s fibres and 
horizontal cell processes. This layer has reticular structure but as the 
macula is approached it takes a fibrous structure called ‘henle’s fibre 
layer’. The fibres run at first vertically then obliquely near the macula 
and finally parallel to the surface. This  layer is thickest at the macula 
but almost absent at the fovea. There is also progressive disappearance 
of the rods.1 The RPE and choriocapillaries are thicker than at the 
macula. This is important since the macula has no retinal blood vessels. 
At the fovea the layers of the retina are spread aside so that light may 
fall directly on the cones.  
Each cone is connected to only one ganglion cell (in other area 
each ganglion cell connects upto 100 rods). At the center of the fovea 
cone cells are located in a 50u diameter area and are separated from 
each other by relatively wide spaces of watery cytoplasm belonging to 
muller’s fibres. The thinness of the basal lamina and the watery 
cytoplasm allow the light to pass through.2 
Anatomical peculiarities of macula causing an exaggerated response 
to pathological process 
Peculiar susceptibility of the macula to a number of pathological 
process both local and generalized is called’ exaggerated response’ of 
the macula.3 The causes for this are listed below- 
1.  Vascular supply: 
The arcade arrangement of the capillaries which arise as terminal 
parts of an end artery system, together with the central avascular zone 
make fovea a water shed. Local impairment of  metabolism, whether 
from disturbances in perfusion and accumulation of metabolites or from 
the effects of capillary damage, lead to extracellular fluid  accumulation  
at a quicker rate than what can be absorbed. 
2.  Tissue architecture 
The processes of muller’s cells run horizontally in the Outer 
plexiform layer, hence retina loses its compact nature and this laxity 
enables large quantities of extracellular fluid or exudates to be 
accommodated in the macular region leading to characteristic cystoids 
macular odema. 
3.  Cellular constituents 
The ganglion cells have high metabolic rate and their dysfunction 
due to any cause leads to rapid accumulation of tissue metabolites. Most 
of them have vasodilator effect and this along with underlying hypoxia 
can lead to CME. 
4. Internal limiting membrane 
The vitreous is an excellent diffusing medium and the ILM 
provides  little additional interference to the progress of toxic substances 
arising from the iris, peripheral choroid and parsplana. These  
substances may traverse the vitreous and because of the thinness and 
adherence of the ILM in the foveal region, may preferentially disturb the 
function of the cells which are highly concentrated around foveal rim, 
and also affect the macular permeability 
5.  Choroid and RPE 
 The macular choroid and the RPE are also the preferential sites 
for degenerative changes which may be hereditary, toxic or 
atherosclerotic. There is a predisposition for choroidal vascular diseases 
with decompensation and hemorrhage in the central area which is 
thought to be because RPE in the fovea is very active metabolically 
hyperactivity along with the special haemodynamic effects of the 
narrow choroidal capillaries may lead to increased susceptibility. 
  
PATHOGENESIS OF DIABETIC MACULAR 
ODEMA (DME) 
Diabetic macular odema( DME) 
It is the most common cause of moderate visual impairment in 
patients with NPDR. It occurs as a result of the blood retinal barrier 
which leads to accumulation of fluid within the intraretinal layers of the 
macula . Its incidence increases with the type of diabetes( more common 
in type 2) duration of DM, age of onset, uncontrolled DM, associated 
risk factors like hypertension, hyperlipidemia, anaemia, nephropathy.  
Epidemiology of DME 
Macular odema  increases 3% in mild NPDR, 38% in severe 
NPDR and 71% in PDR. 
1. Blood  retinal barrier:(BRB) 
The common pathway that results in DME is disruption of BRB. 
It compartmentalizes the the neurosensory retina from the  vascular 
component of the eye. It consists of two major components: the outer 
barrier and inner barrier. The  inner barrier is biological unit formed by 
tight junctional complexes between retinal vascular endothelium and 
glial cells and the outer BRB is formed by tight junctions between the 
retinal pigment epithelial cells. The permeability of both components of 
BRB may be increased in diabetic patients. 
The mechanism of the BRB breakdown is multifactorial. It is 
secondary to changes in the tight junctions, pericyte losss, endothelial 
loss, retinal vascular endothelium and RPE cells, activation of AGE 
receptor, down regulation of glial cell derived neurotrophic factor, 
retinal vessel dilation and vitreoretinal traction 
2. Vaso active factors:  
Sustained hyperglycemia affects several vasoactive factors eg; 
VEGF, protein kinase C, heparin, angiotensin II, PEDF,  
metalloproteinases and biochemical pathways in diabetes, which  may 
influence the development of structural and functional changes in 
diabetic retinopathy. Hypoxia and hyperglycemia upregulate VEGF 
production in diabetic retinopathy which in turn increases 
vasopermeability by activating  PKC, hyperglycemia increase PKC and 
angiotensin II both of which cause vasoconstriction and worsening of 
hypoxia by their effect on endothelins. 
 
3. Vitreoretinal interface: 
DME may be exacerbated due to persistent vitreomacular traction 
by residual cortical vitreous on the macula after PVD. Thickened and 
taut posterior hyaloid that may or may not be adherent to ILM, macular 
traction due to tractional proliferative membranes or loculation of 
cytokines in the pre macular vitreous pocket lead to DME  
 
Clinical features 
         Diabetic macular odema has following features 
1. Thickening of macula 
2. Blurring of underlying choroidal vascular pattern 
3. Loss of foveolar light reflex if foveola is involved 
4. Cystoids spaces 
5. Lipid exudation from leaking microaneurysms forming 
circinate retinopathy  
  
DIAGNOSIS OF DME 
This is best detected by slit lamp biomicroscopy with + 90 D,  
78D ,or macular contact lens. Fundus fluorescein angiography is  
standard method used to evaluate patients with DME that is sensitive for 
qualitative detection of fluid leakage. OCT aids in quantification of 
retinal thickening and for classification. 
OCT has its role in diagnosis and quantification of retinal 
thickening, macular volume, retinal morphology and vitreoretinal 
relationship in DME. It is also important in defining the indication of 
surgery, determining the prognosis and quantifying the response to 
therapy.The main pathology in DME is accumulation of fluid 
intraretinally. This is seen as reduced backscattering seen most 
commonly in the Outer retinal layers.3 
Clinically significant macular odema( CSME) 
Thickening of the retina< 500 microns from the center of the 
macula. Hard exudates with thickening of the adjacent retina located 
500 microns from the center of the macula. A zone of retinal thickening, 
1 disc area or larger in size located 1 disc diameter from the center of 
the macula 
CLINICALLY SIGNIFICANT MACULAR ODEMA( CSME)
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    Fig.2 moderate NPDR
   Fig.4 Hard exudates on 
   the fovea  
 
 
 
FFA CLASSIFICATION 
1.  Focal maculopathy: 
Areas of focal leakage from microaneuyrsms and dilated capillary 
segments. These focal areas of thickening are delinated from adjacent 
healthy retina by complete or partial ring of hard exudates. Focal odema 
show leakage in the late phase 
2. Diffuse maculopathy 
Areas of leakage from IRMA, retinal capillary bed Breakdown of 
blood retinal barrier with from microaneurysm and dilated capillary bed 
throughout posterior retina causes diffuse odema. It  differs from focal 
odema by: 
1. Diffuse odema usually not associated with hard exudates.  
2. Even when odema resolves spontaneously it does not leave 
hard exudates  
3. Cystoids spaces develop more commonly in DME. It is visible 
clinically, but seen better in late phase of FFA and OCT as 
hyperreflective septa 
4. Mostly bilaterally symmetrical 
5. May disappear spontaneously at the same time in both eyes 
even without laser only to reappear spontaneously. 
6. Systemic factors associated with exacerbation is 
hypertension, hyperlipidemia, anemia 
3. Ischemia maculopathy 
Ischemia type of lesion has the following  
- Enlargement of FAZ  
- irregularities of FAZ  
- capillary budding FAZ 
- widening of intercapillary space and capillary drop out in  
the perifoveal area. 
4.Mixed maculopathy- It is a combination of focal  maculopathy 
and diffuse maculopathy. 
  
FFA CLASSIFICATION
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Fig 5 focal  maculopathy 
 
 
 
 
 
 
 
 -6 Diffuse maculopathy 
 
 
 
7 Ischemic  maculopathy 
OCT CLASSIFICATION 
1. Spongy odema: It is the most common presentation, Cross 
sectional scans show swelling of the retina giving spongy 
appearance with increased retinal thickness. Back scattering seen 
from intra retinal fluid accumulation. It is confined mostly in 
outer retinal layers while internal layers maintain their normal 
reflectivity.5 
2. Cystoid odema:It is the second most common which shows Intra 
retinal cystoids   spaces. Involves variable depth of retina has 
intervening septa in between. Progresses gradually to involve the 
whole of the retinal thickness.   
3. Serous detachment- It is seen as a hyporeflective area between 
nerosensory retina and RPE. 
4. Taut posterior hyaloid membrane: Taut thickened shiny 
glistening hyper reflective membrane with striations on retina 
over the posterior pole with attachment to the disc and top of the 
elevated macular surface. Retinal thickness is greatly increased 
with intra retinal hypo reflective cyst like cavities. May also 
present as macular odema with foveal detachment 
5. Vitreomacular traction- it is seen as a hyporeflective membrane 
extending from  the vitreous to the macula.It causes detachment 
of fovea. Its an indication for pars plana vitrectomy. Laser will 
worsen macular odema.5 
Treatment of DME 
Laser therapy has been part part of treatment since mid 1980’s. 
The goal of macular laser photocoagulation is to limit vascular leakage 
through focal laser burns of leaking microaneuyrsm or grid laser burns 
in areas of diffuse break down of the blood retinal barrier.  
Frequency doubled Nd :Yag laser (532nm) is laser choice in the 
management of DME. The laser is to photocoagulate leaking 
microaneuyrsm 500u away from the centre of macula   Grid laser done 
for patients with diffuse macular odema using double frequency Nd yag 
laser 532 nm. Contact  lens used Goldman 3 mirror lens or Mainster 
high magnification or standard.5  
 Duration- 100- 200ms 
 Spot size- 50 – 100 microns 
 Intensity-mild to moderate  
 1 burn width apart, 500u from centre of macula and 500u from 
temporal margin of disc.  
  
CONTRAST SENSITIVITY 
Contrast  is the ability to perceive slight changes in  luminance 
between regions that are not separated by definite borders. Loss of  
Contrast sensitivity is more important and disturbing for the patient than 
is the loss of visual acuity.6 
 Contrast sensitivity determines how well a person sees faces in a 
crowd, read a newspaper or drives an automobile at night. These are 
questions pertaining to person’s quality of life and quality of vision. To 
obtain answers to these  questions we need to assess the person’s 
functional vision. The conventional measurement of visual function like 
snellen’s acuity, colour vision and visual fields do not provide us with a 
complete picture of patient’s quality of vision. Snellen’s acuity is 
measure of resolution, the smallest size black on white letters a person 
can read. But objects in the real world come with a wide a range of 
contrast.6 
Types of Contrast sensitivity 
1. Spatial Contrast sensitivity :  It refers to detection of striped 
patterns at various levels of contrast and spatial frequencies. 
Patient is presented with sine wave gratings of parallel light and 
dark bands( arden gratings) and is asked to tell the minimum 
contrast at which the bars can be seen at each frequency.7 
2. Temporal Contrast sensitivity: Here the contrast sensitivity 
function is generated for time related (temporal) processing in the 
visual system by presenting a uniform target field modulated 
sinusoidal in time rather than as a function of spatial position. 7 
Measuring contrast sensitivity  
There are three variables in the measuring contrast Sensitivity 
The average amount of light reflected depend on:  
1. Illumination of paper and darkness of ink 
2. Degree of blackness in relation to the white background i.e 
contrast 
3. The distance between the grating periods or cycles per degree of 
visual angle 
Arden gratings 
The Arden plates introduced formally in 1978 consisted of  
booklet of seven plates with sine wave gratings ranging from 0.4 to 0.6 
cpd at a distance of 57cms. Sine wave gratings, which are alternating  
dark and light bands are used to assess the function of contrast 
sensitivity. It was gold standard target for evaluating contrast sensitivity           
because they test individual visual channels in the most sensitive. Due to 
the high  false positive rates associated with set up newer modalities 
were divised. 8                   
The Cambridge low contrast grating:  
It  is simple and rapid test for contrast sensitivity. It is a set of ten 
plates containing gratings in a spiral bound booklet.  To perform the test 
booklet is hung on a wall at distance of 6m. The pages are presented in 
pairs one above the other.  One page in each pair contains gratings and 
the other is blank. The subject is simply required to choose which page, 
top or bottom contains gratings. The pages are shown in order of 
descending contrast and are stopped when the first error is made.9 
Vis Tech chart 
The first grating chart that could be mounted on wall is  Vis Tech 
chart. This consists of six rows of sine wave grating patches tilted in 
different orientations used at distance of 3m from the subject. In this test 
contrast is assessed at several spatial frequencies and subject has to 
identify the orientation of the grating i.e whether vertical or 15 degree 
clockwise and anti clockwise. The CSV-100( vector vision) is another 
grating based chart. It has an retro-illumination system.9  
 
 
  
    
 
 
 
 
                         Fig 8 showing Pelli Robson chart
 
 
 
 
 
Fig 
Contrast Sensitivity
Visual acuity Chart
 
9 showing ETDRS chart 
 Chart 
 
The Pelli - Robson Contrast Sensitivity Charts 
It consists of 8 rows of six letters of constant size arranged in 16 
groups of three. This chart consists of letter which subtend angle of 3 
degree at a distance of 1m. All the letters are of same size but decreasing 
in contrast every group of 3. Contrast of the test letters decreases from 
near 100% at the top to less than 1%. When contrast is 0%, there is no 
edge between the two adjacent areas—that is, no pattern is physically 
present. For any value greater than 0%, an edge exists though it may or 
may not be visible, depending on the image-processing capabilities of 
the detector.6 At  the bottom of the chart in 0.15-log unit sensitivity 
steps for each triplet of letters. The log contrast sensitivity varies from 
0.00 to 2.25.7 
The chart was used at 1 m at a mean luminance of 85 cd/m2  
(i.e.illumination of approx 280 lux).The dimension is 97 x 82 cm8.While 
recording subject sits directly in front of chart at distance of 1m with 
best correction. The subject is made to name or outline each letter on the 
chart starting from the upper left corner and reading horizontally across 
the line each eye tested separately. Subject is made to guess even when 
he or she believes that the letters are invisible. The test is concluded 
when the subject guesses two of the three letters of the triplet 
incorrectly. The subject’s sensitivity is indicated by the finest triplet for 
which two of the three letters are named correctly.8 
The chart is good test–retest reliability, availability of published 
normative data  have led to its frequent choice for epidemiologic studies. 
Contrast is expressed as a percentage, from 0% to 100%.  
 
 
 
 
 
 
 
 
 
 
 ETDRS CHART  
ETDRS acuity testing has become the standard for testing visual 
acuity, replacing the Snellen. ETDRS stands for Early Treatment 
Diabetic Retinopathy Study. The ETDRS acuity test was developed to 
aid in evaluating the changes in vision following panretinal 
photocoagulation in patients with diabetic retinopathy The ETDRS test 
is designed to eliminate inaccuracies in the Snellen acuity tests.10 
Fallacies in Snellen chart 
• Snellen acuity test has a variable size and number of letters per 
row.  
• Poor vision lines have 1 or 2 letters, good vision lines have 8 
letters Therefore, if the results of a study showed that the patients 
"gained three letters of acuity," the results could indicate the gain 
of a full acuity line.  
• The  individual lines on the Snellen acuity test are not equally 
spaced. For example, the change from the 20/25 line to the 20/20 
line is a 20% change, while the change from the 20/30 line to the 
20/25 line is a 16% change. Crowding phenomenon- when letters 
are spaced too closely there is an effect from adjacent contours 
that reduces  the visual acuity 
• Letters are not always of same legibility, few letters are easier to 
read ( C,D,E,O,G) than (A,J,L) 
•
 Lack of standardised progression between lines missing of 1 letter 
on good acuity lines has less effect than missing 1 letter in poor 
vision lines.11 
ETDRS Design 
The ETDRS test incorporates specific design criteria to make it 
more accurate than the Snellen acuity tests. These include: 
• Same number of letters per row (five letters per row) 14 rows 
total of 70 letters.  
• There is consistent spacing between the letters and rows 
proportional to the size of the letter 
• Equal spacing of the rows on a log scale (the rows are separated 
by 0.1 log unit). Spacing between letters is equal to the width of 
letter. 
• Equal spacing of the letters on a log scale. Spacing between row 
equal to the height of next row letter. 
•
 Equal lo interval (ratio of 1.26X) in the progression of letter size 
between lines. The letters double in size in every third line.11  
ETDRS Standardization  
Using the best correction in a trial frame, ETDRS chart was 
placed 4 meters from the patient in a back-illuminated stand. The 
ETDRS chart was printed with high-contrast lettering on a translucent 
white polystyrene panel lit from behind and displayed in a standard light 
box. The light box was illuminated by two fluorescent lamps with a 
reusable fenestrated sleeve (diffuser) that produced a chart luminance, 
measured by a digital light meter of 168 cd/m2, which is in compliance 
with recommendations of the ETDRS protocol (80 to 320 cd/m2). 
Scoring the ETDRS Chart 
ETDRS Scoring Method 1:  
The patient starts are the top of the chart and begins to read down 
the chart. The patient reads down the chart until he or she reaches a row 
where a minimum of three letters on a line cannot be read. The patient is 
scored by how many letters could be correctly identified. If a patient 
could not read the largest letters at 4 meters, then the chart was moved 
50% closer to the patient  (4 meters to 2 meters, or 2 meters to 1 
meter).ETDRS Score is a  letter score is calculated based on the number 
of letters that can be correctly identified from specified distances. 
Higher letter scores correspond to better visual acuity. Lower letter 
scores mean poorer visual acuity.12 
ETDRS Letter 
Score* 
Snellen Visual Acuity  
Equivalent 
25 6/95 
30 6/76 
35 6/60 
40 6/48 
45 6/38 
50 6/30 
55 6/24 
60 6/19 
65 6/15 
70 6/12 
75 6/10 
80 6/8 
85 6/6 
 
* ETDRS Score = number of letters read plus 30 
 
 
 
 
ETDRS Scoring Method 2:  
The ETDRS charts were originally used in ETDRS studies where 
patients had relatively poor vision. For these patients, a second scoring 
method is used. The patient starts on the last row where he or she can 
read all of the letters, and then reads down until he or she reaches a row 
where a minimum of three lines cannot be read. For these patients, a 
decimal ETDRS acuity score can be used. To calculate the decimal 
acuity score, follow the guidelines below. Determine the last row where 
the patient can correctly identify all 5 letters on that row. 
Determine the log score for that row (these scores are shown in 
the margin of the ETDRS test, e.g. the 20/25 line has a log score of 0.1) 
subtract 0.02 log units for every letter that is correctly identified beyond 
the last row where all of the letters are correctly identified. For example, 
if the patient reads all of the letters correctly on the 20/30 row and then 
3 letters correctly on the 20/25 row, the Log Score would be calculated 
as follows: 
20/30 Row = 0.20 3 letters X 0.02 log/letter = - 0.06 
  
Laser photocoagulation 
During the 1940s, German ophthalmologist  Meyer-Schwickerath 
pioneered light coagulation of the retina. The ideal wavelength is 
characterised by good penetration through ocular media and maximal 
absorption in the target tissue. Shorter  wavelengths are more easily 
scattered, hence, red light (620 - 750 nm) has better penetration than 
blue light (450-495 nm). Scatter is a result of radiation absorption by 
tissues other than the target. The extent of laser absorption is also 
dependent upon the pigment composition of the target tissue. The three 
major ocular pigments are melanin, xanthophyll and haemoglobin. The  
major site of laser absorption is in the melanin containing retinal 
pigment epithelium (RPE) and choroid.  
Xanthophyll  has maximal absorption of blue light and is found 
predominantly in the macula. Haemoglobin has poor red light absorption 
but excellent blue, green and yellow light absorption. The green 
wavelength is superior due to minimal absorption of xanthophyll 
coupled with strong affinity for melanin and haemoglobin. Therefore it 
can be used in the macular region as well Goldmann as the periphery, 
and can target abnormal vessels. Yellow laser has similar to green laser, 
with a few advantages. This longer wavelength scatters less than green 
and its absorption by haemoglobin is at least twice that of green laser, 
making it a more effective laser for vascular structures.Despite being 
considered the best wavelength to treatvascular lesions, its application 
has been limited by the costliness and bulkiness of krypton yellow lasers 
(568.2nm) Green laser is available in two systems: argon gas (514.5nm) 
and solid state frequency doubled Nd-YAG (532nm)and diode laser that 
utilise crystals and semiconductors respectively. Its beam is near 
infrared at 1064nm, however, frequency doubling achieved by a 
potassium-titanium phosphate (KTP) crystal halves the wavelength 
resulting in green laser. The solid-state lasers are becoming the preferred 
option due to their portability and ability to deliver laser in continuous 
and pulse mode. 
 
 
 
 
 
 
 Laser Wavelengths 
 
 
Grid laser contact lens 
Fig 11 Mainster high magnification lens  Fig 12 Goldmann 3 mirror contact lens 
 
 
    
 
 
 
 
Fig 10  Graph showing absorption spectrum of various pigment in the retina 
Laser Delivery Systems 
Laser photocoagulation can be applied to the retina via 
transpupillary laser either performed on slit lamps through specialised 
contact laser lenses, or with binocular indirect ophthalmoscopy through 
non-contact lenses.  
Grid laser lenses 
Contact Lens 
Spot 
magnification 
Field of view 
(degree) Image 
Goldmann 1.08 36 Virtual erect 
Volk area centralis 0.95 82 Real inverted 
Mainster high 
magnification 
0.81 75 Real inverted 
Mainster standard 1.05 90 Real inverted 
 
Grading of laser burns 
Grade 1( light)- barely visible, blanching of pigment epithelium 
Grade 2(mild)-faint blanching 
Grade 3(moderate)- grey, dirty white 
Grade 4(severe)- dense chalky white 
 
New and Future Innovations: 
Subthreshold laser system  
Retina Regeneration Therapy is currently being evaluated. It is a 
532 nm laser that produces 3 nanosecond pulses. The energy level of 
pulses delivered are lower than those of micropulse laser with adjustable 
on and off times and therefore it stimulates renewal of RPE rather than 
destroy it. Its proposed utility is in the treatment of diabetic 
maculopathy. The length of these pulses needs to be shorter than the 
thermal relaxation time of the target tissue, that is the time required for 
heat to be transferred away from the irradiated tissue. 
Pascal (Pattern scan laser)  
Photocoagulator is a 532 nm frequency-doubled Nd:YAG solid-
state laser. It is a semiautomated system that delivers laser pulses in a 
rapid, predetermined sequence with a variety of laser spot patterns and 
sizes. The main benefits are thought to be greater accuracy and faster 
treatment with a time reduction from 100-200 ms per burn in 
conventional photocoagulation compared with 10-20ms per burn with 
been assessed as a mode of delivering PRP and macular grid laser.  
  
CLINICAL EVALUATION CLINICAL SIGNIFICANT 
MACULAR ODEMA 
Visual acuity:  
Loss of vision depends on the involvement of macula. It is 
assessed by Snellens chart, more accurate would be ETDRS chart 
Colour vision:  
The most common defect observed is blue yellow. The defects 
best detected by Fansworth munsell 100 hue test  
Indirect opthalmoscope:  
This technique is of special importance because it allows the 
examiner to integrate the view of the entire retina  
Slit lamp biomicroscopy using 90 D, 78D, Goldmann 3 mirror 
contact lens helps to visualize stereoscopic examination of macula 
Threshold amsler grid testing: this is rapid sensitive and high yield 
means of assessing the central fields in patients with diabetic retinopathy 
Photo stress test: after images and central scotomas persist after 
long time. This explained the prolonged re adaptation time in photo 
stress test in the affected eye 
ELECTROPHYSIOLOGY 
Electro Retinography:   
Early stages of diabetic retinopathy may reveal abnormalities of 
oscillatory potential in the ascending limit of b-wave. Delay in implicit 
time occurs as macular odema progresses 
Electrooculography:  
This test may reveal abnormal light to dark ratio (arden ratio) 
Visually evoked responses:  
The macular disease with odema the VER shows amplitude 
reduction depending on the visual acuity with no change in latency 
Fundus fluorescein angiography:  
This is one of the mandatory investigations needed in macular 
odema: 
1. Confirmation of diagnosis 
2. Documentation of lesion 
3. Deciding about the management 
4. Follow up 
OCT 
This investigation modality can be used for diagnosis and follow 
up.  It is non invasive technique can quantify the macular thickness 
1. Spongy odema: It is mostly confined to outer retinal layers due to 
back scattering from intraretinal fluid  
2. Cystoid odema: The cystoid spaces are confined to outer retina 
mostly. In long standing cases they fuse to form large cyst. 
3. Serous detachment:It is seen as a  hypo reflective space  below 
the fovea. It may disappear following laser 
4. Taut posterior hyaloid membrane 
5. Vitreomacular traction:  
Evolving therapies for clinically significant macular odema  
1. Laser photocoagulation  
The goal of Laser photocoagulation for DME is to limit vascular 
leakage through focal laser burns of leaking microaneurysms or grid 
laser burns in areas of diffuse break down of blood retinal barrier.  
Moderate visual loss was reduced by 50% in patients who 
received laser therapy in the ETDRS. Double frequency Nd:YAG lasers 
(532nm) is the lasers of choice in the management of DME. The  
Treatment strategy given by ETDRS is to photocoagulate all 
leaking microaneurysms further than 500u from the centre of macula 
and to place grid of 50 -100um burns in areas of capillary leakage and in 
areas of capillary non perfusion. Complications are RPE atrophy, laser 
scars, sub retinal fibrosis can lead to visual loss. 
Focal laser for micro aneurysms or grid photocoagulation in 
diffuse macular odema where leakage from capillaries. The Early 
Treatment for Diabetic Retinopathy Study( ETDRS) established the 
indications and guidelines for laser treatment in DME. Laser Treatment 
is indicated for CSME which is defined by atleast one of the following: 
• Thickening of the retina< 500 microns from the center of the macula 
• Hard exudates with thickening of the adjacent retina located 500 
microns from the center of the macula 
• A zone of retinal thickening, 1 disc area or larger in size located 1 
disc diameter from the center of the macula 
2. Intravitreal corticosteroid 
The rationale for the use of corticosteroids in CSME is it 
stabilises blood retinal barrier. It inhibits VEGF and other  Cytokines 
growth factors that regulate endothelial tight cell junctions. They also 
reduce the synthesis of prostaglandins and leukotrine, two potent 
inflammatory mediators. The resultant anti inflammatory effect 
contributes to the reduction of macular odema. Increased diffusion by 
modulation of calcium channels could also account for the efficacy of   
corticosteroids reducing of macular odema. IVTA reduces retinal 
thickeneing on OCT and improves vision in a substantial number of 
patients. Patients with cystoids macular odema respond better.  
However  duration of effect varies and visual decline are often 
observed 4 to 6 months after injection. Repeated therapy is often limited 
by side effects. Intraocular pressure elevation occurs in about one third 
of patients. Acceleration of cataract formation, endophthalmitis and 
retinal detachment are the other complications. 
 
3. Intravitreal anti VEGF agents  
Anti VEGF agents  work to restore the normal permeability of 
blood retinal barrier.VEGF increases vascular permeability by relaxing 
endothelial junctions. Inhibition of  VEGF blocks this effect to some 
extent. 
Ranibizumab (lucentis) is a humanized antigen binding 
fragment(Fab) of a second generation, recombinant monoclonal 
antibody directed against VEGF. It has high specificity and affinity for 
all soluble human isoforms of  VEGF.  
Bevacizumab (avastin) is a full length humanized monoclonal 
antibody for treatment of metastatic colorectal cancer, Intravitreal 
formulation was first used off label for the treatment of age related 
macular degeneration. In cases of diffuse odema that failed other 
treatments, Intravitreal injection of  Bevacizumab was associated with 
improved vision and decreased retinal thickness 12 weeks after the first 
injection. Pegatanib sodium (macugen) is an anti VEGFaptamer blocks 
the effect of  VEGF-165  
 
4. Protein kinase C Inhibitor 
Protein kinase C is upregulated in hyperglycemia in multiple 
tissues vascular endothelial cells. Oral administration of ruboxistaurin 
32mg/day over a period of 36 months have demonstrated the efficacy in 
prevention of sustained moderate vision loss in non proliferative 
diabetic retinopathy by reducing the macular odema within 100 microns 
from the centre of the macula and the need for intial laser treatment . 
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 AIM OF THE STUDY 
 PRIMARY OBJECTIVE 
1. To assess the improvement in contrast sensitivity with 
 Pelli Robson chart after grid laser  
2. To quantify assessment of macular thickness by OCT.  
SECONDARY OBJECTIVE 
To assess the improvement in visual acuity with ETDRS chart 
after grid laser. 
SAMPLE SIZE 
 A total of 50 patients were studied. 
INCLUSION CRITERIA 
1. Patients with Non Proliferative Diabetic Retinopathy with          
Clinically significant macular odema (CSME)  
2. Visual acuity 6/24 or better  
 EXCLUSION CRITERIA 
1. Psuedophakia  
2. Age related macular degeneration  
3. Glaucoma 
4. Proliferative diabetic retinopathy 
5. Post pan retinal photocoagulation  
6. Ischemic maculopathy 
  
MATERIALS AND METHODS 
 This study was intended to evaluate the efficacy of grid laser 
photo coagulation on contrast sensitivity in patients with CSME which 
was carried out in the department of Retina services of RIOGOH, 
Chennai from June 2010 to June 2011. All the patients who were 
referred to retina clinic with Diabetic CSME were screened and selected 
for the study. 
Detailed history was taken from all the patients regarding the 
duration and treatment for Diabetes. Contrast sensitivity is recorded with 
Pelli- Robson chart.Visual acuity recorded with ETDRS chart. Intra 
Ocular Pressure is measured by applanation tonometry. Anterior 
segment examination with slit lamp biomicroscopy was done. Posterior 
segment examination with 90 D, binocular  Indirect opthalmoscope and 
a detailed fundus drawings were done and fundus photo was taken for 
documentation. Fundus flourescin angiography (FFA) and Optical 
coherence topography( OCT) were done for all patients. Biochemical 
marker HBA1C level was documented. These patients are treated with 
grid laser and followed up over 3 months Grid laser done for patients 
with diffuse macular odema using double frequency Nd yag laser 
532nm. The parameters of grid laser are: 
Duration- 100- 200ms 
Spot size- 50 – 100 u 
Intensity-mild to moderate  
One burn width apart,500u from centre of macula and 500u from 
temporal margin of disc.  
Guidelines for Follow up: 
Patients were followed up over a period of 4 weeks, 8 weeks, 12 
weeks for improvement in contrast sensitivity with pelli robson chart, 
visual acuity by ETDRS chart during follow up. Quantitative analysis of 
macula thickness was documented by OCT. 
   
 
 
 
 
 
  
OBSERVATIONS AND RESULTS 
Table 1:  Age distribution
Age distribution
31 - 40 
41 - 50 
51 -60 
61 - 70 
 
Most of the patients in our study were in the age group of 51 
(34%) 
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 No of patients Percentage
14 28 
11 22 
17 34 
8 16 
Table 2:  Sex distribution 
41-50 51-60 61-70
age in yrs
AGE DISTRIBUTION
 
 
-60 yrs 
Sex No of patients Percentage 
Male 32 64 
Female 18 36 
 
 
  
64%
36 % 
Sex distribution
male female
Table 3.1: Results of visual acuity by ETDRS chart (after 3 months) 
No of letters 
improved 
on ETDRS chart 
ETDRS Score = no of letters 
read plus 30 at distance of 
4m 
Eyes 
5 letters 
Score from 40 to 45 10 
Score from 45 to 50 22 
Score from 50 to 55 22 
Score from 55 to 60 10 
Score from 60 to 65 2 
10 letters 
Score from 45 to 55 14 
Score from 50 to 60 6 
15 letters Score from 50 to 65 4 
No improvement 
Score from 45 to 45 8 
Score from 50 to 50 2 
 
 
66
20
4
10
0
10
20
30
40
50
60
70
5 lettes 
Improvement
10 letters 15 letters no 
improvement
pe
rc
en
ta
ge
Results of visual acuity with 
ETDRS chart after Grid laser
Table 3.2  Results of visual acuity by ETDRS chart (after 3months) 
RESULTS EYES 
Improvement  90 
         5 letters 66 
        10 letters 20 
        15 letters 4 
No  Improvement 10 
 
There was improvement in 90 eyes in the treated eyes, where as 
10 eyes did not show any improvement. With 66% showing 5 letters  
improvement, 20% showing 5 letters improvement, 4% showing 15 
letters improvement aft 12 weeks of grid laser. By chi- square test P 
value was <0.0001 which was statistically significant 
  
Table 4.1: Results of Improvement of Contrast sensitivity  
in Pelli Robson chart 
Improvement assessed by 
% loss of contrast sensitivity 
Eyes 
From  30% loss to 20% 2 
From  20% loss to 10% 22 
From  10% loss to 5% 38 
From  5%   loss to 1% 8 
 
Table 4.2: Results of Contrast sensitivity 
Results eyes 
Improvement 70 
No improvedment 30 
 
 
 
Results of contrast sensitivity after Grid laser treatment
In our study there was 
of patients, 30% didnot  show
improved  2 eyes had
from 30% to 20%. 22 eyes showed 
38 eyes showed improve
improvement from 5% lo
<0.0001 which was statistically significant
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Correlation of HbAIC with contrast sensitivity
Most of our  patients with good glycemic 
value of 6-8 mg% had  5 % loss of  contrast sensitivity. 22 
value of 8-10 mg%, had  10
15% loss of  contrast sensitivity had HbA1C of 10 
glycemic  control. 
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 Table-5 Correlation of contrast sensitivity  with visual acuity 
 % loss of Contrast sensitivity Total 
ETDRS 
SCORE 
1 % 5 % 10 % 20 % 30 % 50 %  
40 0 0 0 0 0 2 2 
45 0 0 0 4 10 0 14 
50 0 10 12 2 0 0 21 
55 0 22 14 0 0 0 36 
60 6 8 2 0 0 0 16 
65 2 6 0 0 0 0 8 
Total 8 46 28 6 10 2 100 
 
 
 
 
 
 
 
Correlation of contrast sensitivity  with visual acuity 
 
2 eyes  with ETDRS score  of 40 had  50% loss of contrast 
sensitivity, 4 eyes with score of 45 had  20%  loss of contrast sensitivity, 
10 eyes had 50% loss of contrast sensitivity. 10 eyes with score of 50  
had  5%  loss of contrast sensitivity and 12 eyes had 10%  loss of 
contrast sensitivity. 8 eyes with score of 60 had 5%  loss of contrast 
sensitivity. The chi-square test had P value  < 0.0001 which was 
statistically significant. 
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Table -6   FFA findings showing pattern of leakage 
FFA Pattern EYES 
FOCAL LEAK 35 
DIFFUSE LEAK 48 
MIXED PATTERN 17 
 
Most of the patients in the study 48 eyes had diffuse pattern of  
leakage, 35 eyes had focal leakage, 17 eyes had mixed pattern  leakage. 
Ischaemic maculopathy was excluded from the study as  laser was not 
indicated for such patients. 
Table -7  OCT findings in patients 
 
OCT  FINDINGS EYES 
CYSTOID ODEMA 28 
SPONGY ODEMA 48 
SUBFOVEAL DETACHMENT 16 
1 
Most of the patients in our study included spongy type of macular 
odema (48 eyes) , cystoid  odema in 28 eyes, subfoveal detachment  in 
16 eyes.   
                              Grid laser
 
 
 
Fig13  Fundus picture showing grid laser marks
Fig 14 FFA showing hyperflourescent
the centre and hyperflourescent lesion around it.
 photocoagulation 
 
 
 lesion in 
 
  
 
OCT FINDING IN SPONGY ODEMA 
 
Fig 15  Pre treatment of spongy edema 
 
 
 
 
Fig 16  Post grid laser treatment showing the  
reduction in thickness  
Table  8.1- Pre treatment macular thickness 
MACULAR THICKNESS 
( microns) 
EYES 
200 -250 29 
250- 300 45 
300- 350 16 
350- 400 10 
 
Table  8.2- Post treatment macular thickness 
MACULAR THICKNESS 
( microns) 
EYES 
<200 24 
200- 250 47 
250 -300 25 
300- 350 4 
 
Comparison between pre and post treatment macular thickness 
         Macular thickness showed  significant improvement. Prior to 
treatment  71 % patients had thickness  more than  250 microns  Post 
treatment all patients had  macular thickness  less than 350 microns. 
However reduction in macular thickness  didnot correspond to an 
equivalent increase in visual acuity  and contrast sensitivity cou
to long standing macular odema which leads to photoreceptor
By chi- square test P value was < 0.0001 which was statistically 
significant. 
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DISCUSSION 
This study included 100 eyes of  50  patients in RIOGOH from  
June 2009 to June  2011.  
Age distribution 
Most of the patient in our study were in the age group of 51- 
60yrs (34%)  
Sex  distribution  
In our study male patients were  62 % and remaining 36% being 
females.  
Visual acuity by ETDRS chart 
There was improvement in 90 eyes in the treated eyes, where as 10 eyes 
did not show any improvement. With 66% showing 5 letters 
improvement, 20% showing 5 letters improvement, 4% showing 15 
letters improvement aft 12 weeks of grid laser. As per ETDRS study 
there was reduction in the moderate visual loss. By chi- square test P 
value was < 0.0001 which was statistically significant. 
 
 Contrast sensitivity by Pelli Robson  chart 
In our study there was improvement in contrast sensitivity in 70 eyes. 
And 30 eyes didnot show improvement. Among patients who didnot 
improvement, 9 patients( 18 eyes) had poor glycemic control, 3 patients 
(6 eyes) had hard exudate on the fovea and 3 patients (6 eyes) had 
chronic persistent CSME. By chi- square test P value was < 0.0001 
which was statistically significant. 
Correlation of contrast sensitivity with visual acuity 
Contrast sensitivity can be impaired even in the presence of 
normal visual acuity. As per study  visual acuity with 6/24 or better only 
were included in the study.2 eyes  with ETDRS score  of  40 had  50% 
loss of contrast sensitivity, 4 eyes with score of 45 had  20%  loss of 
contrast sensitivity, 10 eyes had 50% loss of contrast sensitivity. 10 eyes 
with score of 50  had  5%  loss of contrast sensitivity and 12 eyes had 
10%  loss of contrast sensitivity. 8 eyes with score of 60 had 5%  loss of 
contrast sensitivity. There is no significant association between visual 
acuity and Contrast sensitivity. 
  
Macular thickness in OCT 
Macular thickness showed  significant improvement. Prior to 
treatment  71 % patients had thickness  more than  250 microns.  Post 
treatment all patients had  macular thickness  less than 350 microns. 
However reduction in macular thickness  didnot correspond to an 
equivalent increase in visual acuity  and contrast sensitivity could be due 
to long standing macular odema which leads to photoreceptor damage 
  
CONCLUSION 
Contrast sensitivity is an important aspect of visual function and 
is even more important for ordinary daily tasks than visual acuity. Loss 
of  Contrast sensitivity is more important and disturbing for the patient 
than is the loss of visual acuity 
 Visual acuity was recorded by ETDRS chart  due to the fallacies  
associated in Snellen shart. The Contrast sensitivity was recorded by 
Pelli Robson’s chart was sensitive and reproducible. 
Grid laser photocoagulation in CSME helps in improving the 
contrast sensitivity and stabilizes the visual acuity.  
The changes in contrast sensitivity and visual acuity are 
independent of each other.  
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PROFORMA 
Name   
 
Age  
 
Sex  
 
Occupation 
 
OP no 
 
Address 
 
Phone no 
 
Chief complaints  
 
H/o defective vision 
 
H/o distorted vision 
 
Past history  
 
Diabetes – duration  
 
                  TypeI/II 
 
                   Drug  
 
                   PRP  
 
Hypertension- duration 
                 
                       Medication 
                 
                       Associated IHD, hyperlipidemia 
H/o cataract  surgery in the past 
General physical examination 
PR                                                   CVS 
BP                                                    RS 
Ocular examination 
                                                     RE                            LE 
Visual acuity by Snellen  
Visual acuity by ETDRS  
 IOP by applanation 
Contrast sensitivity by Pelli Robson chart   
Conjunctiva  
Cornea  
Iris      
Ant chamber  
Lens 
Slit  lamp examination 
Fundus  by 90D, IDO 
Fundus flourescein angiography 
Optical coherence tomography 
Investigations 
FBS, PPBS, HbA1c, 
Lipid profile 
Renal  function  test 
Diagnosis  
Treatment: grid laser photocoagulation  
Power, Spot size, duration 
Follow up and outcome of the treatment 
 
 
  
KEY TO MASTER CHART 
Vn  - vision 
pH  - pin Hole 
Nip   - not improving with pin hole  
M  - Male 
F   - Female 
ETDRS - Early Treatment Diabetic Retinopathy Study 
NPDR -  Non proliferative diabetic retinopathy 
CSME - Clinically significant macular odema 
OCT - Optical coherence tomography 
 
 
 
MASTER CHART
RIGHT 
EYE
LEFT 
EYE
RIGHT 
EYE
LEFT 
EYE
RIGHT 
EYE
LEFT 
EYE
RIGHT 
EYE
LEFT 
EYE
RIGHT
 EYE
LEFT
 EYE
RIGHT 
EYE
LEFT 
EYE
RIGHT 
EYE
LEFT
 EYE
RIGHT 
EYE
LEFT 
EYE
1  60 m be severe NPDR 6/24 NIP 6/24 ph 6/18 45 50 30 20 370 290 6/24 ph 6/18 6/24 ph 6/18 45 45 20 20 306 260
2 sekar 45 m be moderate NPDR 6/12 ph 6/9 6/12 ph 6/9 50 50 20 20 240 240 6/12 ph 6/9 6/12 ph 6/9 55 55 10 10 200 200
3 saroja 55 f be moderate NPDR 6/18 nip 6/12 ph 6/9 50 50 20 20 362 275 6/12 nip 6/9 nip 55 55 10 10 260 240
4 hamsapathy 59 m be severe NPDR 6/24 nip 6/24 nip 45 45 30 30 290 290 6/24 nip 6/24 nip 45 45 30 30 260 260
5 lalitha 35 f be mild NPDR 6/12 ph 6/9 6/12 ph 6/9 55 55 10 10 240 240 6/12 ph 6/9 6/12 ph 6/9 60 60 5 5 180 180
6 Gopinath 39 m be mild NPDR 6/12 ph 6/9 6/12 ph 6/9 55 55 10 10 280 260 6/12 ph 6/9 6/12 ph 6/9 60 60 5 5 210 210
7 kuppammal 60 f be moderate NPDR 6/18 ph 6/12 6/18 ph 6/12 50 50 20 20 390 390 6/12 NIP 6/12 NIP 55 55 10 10 240 240
8 andal 55 f be severe NPDR 6 / 24 NIP 6 / 24 ph 6/18 45 45 30 30 368 338 6/24 NIP 6/24 ph 6/18 45 45 30 30 246 260
9 Marimuthu 58 m be severe NPDR 6/24 ph 6/18 6/24 ph 6/18 45 45 20 20 355 350 6/24 ph 6/18 6/24 ph 6/18 50 50 10 10 295 250
10 kumari 37 f be mild NPDR 6/9 nip 6/12 ph 6/9 60 60 5 5 260 260 6/9 ph 6/6 6/9 ph 6/6 65 65 5 5 200 200
11 gunasundari 58 f be moderate NPDR 6/18 nip 6/18 ph 6/9 45 45 20 20 280 280 6/18 ph 6/9 6/18 ph 6/9 50 50 10 10 246 246
12 venkatesan 34 m be moderate NPDR 6/12 ph 6/9 6/12 ph 6/9 50 50 10 10 334 334 6/12 ph 6/6 6/12 ph 6/6 55 55 5 5 278 278
13 gangadharan 66 m be moderate NPDR 6/24 nip 6/18 ph 6/12 40 40 50 50 220 370 6/24nip 6/24nip 40 40 50 50 220 320
14 ramanathan 40 m be severe NPDR 6/18 ph 6/12 6/18 ph 6/12 45 45 10 10 278 258 6/18 ph 6/9 6/18 ph 6/9 50 50 5 5 218 218
15 selvaraj 56 m be severe NPDR 6/24 ph 6/18 6/24 ph 6/18 45 45 10 10 358 378 6/18 ph 6/9 6/18 nip 50 50 10 5 215 265
16 amudha 36 f be severe NPDR 6/24 ph 6/18 6/24 ph 6/18 50 50 20 20 306 326 6/18 ph 6/9 6/18 ph 6/9 50 50 20 20 270 260
17 sudha 44 f be moderate NPDR 6/18 ph 6/12 6/18 ph 6/12 50 50 10 10 340 310 6/12 nip 6/12 nip 55 55 5 5 286 266
18 johnson david 46 m be moderate NPDR 6/24 ph 6/12 6/24 ph 6/12 45 45 10 10 280 280 6/12 ph 6/9 6/12 ph 6/9 50 50 5 5 216 206
19 sambandam 62 m be severe NPDR 6/24 NIP 6/18 ph 6/12 40 40 30 30 326 356 6/24 nip 6/24 nip 45 45 30 30 310 330
20 ragavan 40 m be moderate NPDR 6/18 ph 6/12 6/18 ph 6/12 45 45 10 10 260 274 6/12 ph 6/9 6/12 ph 6/9 55 55 5 5 190 220
21 durai 57 m be moderate NPDR 6/18 ph 6/12 6/18 ph 6/12 45 45 10 10 256 246 6/12 ph 6/9 6/12 ph 6/9 55 55 5 5 216 206
22 elumalai 45 m be mild NPDR 6/9 ph 6/6 6/9 ph 6/6 55 55 5 5 248 228 6/9 ph 6/6 6/9 ph 6/6 60 60 5 5 200 200
23 paneerselvam 57 m be moderate NPDR 6/18 ph 6/12 6/18 ph 6/12 45 45 5 5 289 250 6/12 ph 6/9 6/12 ph 6/9 55 55 5 5 210 210
24 suguna 40 f be mild NPDR 6/9 ph 6/6 6/9 ph 6/6 50 50 5 5 220 220 6/6 p 6/6 p 60 60 1 1 190 190
25 rukmani 56 f be severe NPDR 6/24 ph 6/18 6/24 nip 45 45 10 10 316 316 6/18 ph 6/9 6/18 ph 6/9 50 50 5 5 278 278
26 subramani 62 m be severe NPDR 6/24 nip 6/18 ph 6/12 40 40 30 30 375 388 6/24 nip 6/24 nip 45 45 30 30 280 280
27 jayaprakash 64 m be moderate NPDR 6/18 ph 6/12 6/18 ph 6/12 45 45 10 10 285 275 6/12 ph 6/9 6/12 ph 6/9 50 50 5 5 220 226
28 anwar 58 m be moderate NPDR 6/18 ph 6/12 6/18 ph 6/12 45 45 10 10 246 264 6/9 ph 6/6 6/9 ph 6/6 55 55 5 5 190 200
29 shakil ahmed 44 m be mild NPDR 6/6 p 6/6 p 60 60 5 5 210 200 6/6 p 6/6 p 65 65 5 5 180 188
30 vimala 60 f be severe NPDR 6/24 ph 6/12 6/24 ph 6/12 45 45 20 20 290 280 6/18 ph 6/12 6/18 ph 6/12 50 50 10 10 220 227
31 amwar 58 m be moderate NPDR 6/18 ph 6/12 6/18 ph 6/12 50 50 10 10 265 268 6/18 ph 5/9 6/18 ph 5/9 55 55 5 5 216 218
32 pushpa 45 f be moderate NPDR 6/18 ph 6/12 6/18 ph 6/12 50 50 20 20 286 268 6/12 ph 6/9 6/12 ph 6/9 55 55 10 10 210 230
33 vijaya 48 f be severe NPDR 6/24 ph 6/18 6/24 ph 6/18 45 45 20 20 266 266 6/18 ph 6/12 6/18 ph 6/12 55 55 10 10 206 206
34 balammal 54 f be moderate NPDR 6/18 ph 6/12  6/12 nip 50 50 20 20 250 340 6/12 ph 6/9 6/12 nip 55 55 10 10 188 228
35 dasappan 35 m be mild NPDR 6/6 p 6/6 p 55 55 5 5 218 218 6/6 p 6/6 p 60 60 1 1 192 190
36 murugan 62 m be moderate NPDR 6/18 ph 6/12 6/18 ph 6/12 45 45 10 10 279 269 6/12 ph 6/9 6/12 ph 6/9 50 50 5 5 216 226
37 chandra 50 m be mild NPDR 6/18 ph 6/6p 6/18 ph 6/6p 50 50 10 10 235 232 6/6 p 6/6 p 55 55 5 5 214 204
38 perumal 65 m be severe NPDR 6/24 ph 6/18 6/18 ph 6/6p 45 45 20 20 274 264 6/18 ph 6/12 6/18 ph 6/12 50 50 10 10 256 236
39 bhaskar 35 m be mild NPDR 6/6 p 6/6 p 55 55 5 5 215 225 6/6 p 6/6 p 60 60 5 5 196 195
40 varadhan 40 m be mild NPDR 6/9 nip 6/9 nip 50 50 5 5 210 210 6/6 p 6/6 p 60 60 1 1 193 195
41 kanniammal 65 f be severe NPDR 6/24 NIP 6/18 ph 6/12p 40 40 30 30 264 264 6/24 ph 6/18 6/24 ph 6/18 45 45 30 30 256 256
42 jayagopal 34 m be mild NPDR 6/9 ph 6/6 6/9 ph 6/6 50 50 10 10 230 230 6/6 p 6/6 p 65 65 5 5 190 190
43 krishnaveni 44 f be moderate NPDR 6/12 ph 6/9 6/12 ph 6/9 45 45 10 10 246 246 6/6 p 6/6 p 55 55 5 5 200 200
44 vellaiyan 62 m be severe NPDR 6/24 ph 6/18 6/24 ph 6/18 40 40 20 20 298 265 6/24 ph 6/12 6/24 ph 6/12 45 45 20 20 280 240
45 lakshmi 39 f be mild NPDR 6/12 ph 6/9 6/12 nip 50 50 10 10 215 200 6/9 ph 6/6 6/9 ph 6/6 60 60 10 10 188 180
46 sundarajan 55 m be moderate NPDR 6/18 ph 6/12 6/18 ph 6/12 45 45 20 20 272 282 6/12 ph 6/9 6/12 ph 6/9 55 55 10 10 234 254
47 shanthi 37 f be mild NPDR 6/9 ph 6/6 6/9 ph 6/6 50 50 5 5 248 230 6/6 p 6/6 p 65 65 1 1 220 210
48 padmavathy 44 m be moderate NPDR 6/12 ph 6/9 6/18 ph 6/12 45 45 20 20 266 278 6/9 nip 6/9 nip 50 50 10 10 225 255
49 gunasekaran 57 m be moderate NPDR 6/18 ph 6/12  6/12 ph 6/9 50 50 10 10 288 260 6/12 ph 6/9 6/12 ph 6/9 55 55 5 5 214 204
50 narayanan 50 m be moderate NPDR 6/18 ph 6/12 6/18 nip 50 50 10 10 310 300 6/12 ph 6/9 6/12 ph 6/9 55 55 5 5 280 270
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